By Hillary Ross
Precision medicine was a late-term focus of the Obama administration, and will remain a national priority as the new regime comes to Washington. The potential benefits number too many to ignore.
As health systems decide on what precision medicine (or personalized medicine) will look like for them, and move toward implementation of that vision, there is a need to recruit strong and innovative leaders. My colleague, Zachary Durst, and I recently had the opportunity to share our thoughts…
